[PHAT] YoY Quarter Result on 30-Jun-2022 [#Q2]

Stock
[PHAT] Phathom Pharmaceuticals, Inc.
Announcement Date
02-Aug-2022
Financial Year
2022
Quarter
30-Jun-2022 [#Q2]
Profit Trend
QoQ- -17.26%
YoY- -39.31%
Quarter Report
PHAT's Result
PHAT's Financial Summary
View:
Show?
Quarter Result
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
Revenue 7,324 0 0 0 0 0 0 -
PBT -91,446 -40,965 -50,920 -36,552 -21,101 -87,762 -257 165.96%
Tax 0 9,618 5,665 1,266 182 1,036 -4 -
NP -91,446 -40,965 -50,920 -36,552 -21,101 -87,762 -257 165.96%
Tax Rate - - - - - - - -
Total Cost 98,770 40,965 50,920 36,552 21,101 87,762 257 169.39%
Ratio Analysis
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
NP Margin -1,248.58 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
EPS -1.56 -0.84 -1.33 -1.00 -0.64 -10.23 -0.05 77.33%
EPS Diluted -1.56 -0.84 -1.33 -1.00 -0.64 -10.23 -0.05 77.33%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.